IBP-9414 will be evaluated in preterm infants with a birth weight of 500-1500g, compared to placebo with regards to efficacy and safety in the prevention of necrotizing enterocolitis.
- Investigator
- Josef Neu
- Status
- Accepting Candidates
- Ages
- N/A - 48 Hours
- Sexes
- All